Toward the discovery of dual HCMV-VZV inhibitors: Synthesis, structure activity relationship analysis, and cytotoxicity studies of long chained 2-uracil-3-yl-N-(4-phenoxyphenyl)acetamides

Bioorg Med Chem. 2015 Nov 1;23(21):7035-44. doi: 10.1016/j.bmc.2015.09.033. Epub 2015 Sep 21.

Abstract

The need for novel therapeutic options to fight herpesvirus infections still persists. Herein we report the design, synthesis and antiviral evaluation of a new family of non-nucleoside antivirals, derived from 1-[ω-(4-bromophenoxy)alkyl]uracil derivatives--previously reported inhibitors of human cytomegalovirus (HCMV). Introduction of the N-(4-phenoxyphenyl)acetamide side chain at N(3) increased their potency and widened activity spectrum. The most active compounds in the series exhibit submicromolar activity against different viral strains of HCMV and varicella zoster virus (VZV) replication in HEL cell cultures. Inactivity against other DNA and RNA viruses, including herpes simplex virus 1/2, points to a novel mechanism of antiviral action.

Keywords: Antiviral; Human cytomegalovirus; Non-nucleoside inhibitor; Uracil; Varicella zoster virus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetamides / chemical synthesis
  • Acetamides / chemistry*
  • Acetamides / toxicity
  • Antiviral Agents / chemical synthesis
  • Antiviral Agents / chemistry*
  • Antiviral Agents / toxicity
  • Cell Line
  • Cell Proliferation / drug effects
  • Cytomegalovirus / physiology*
  • DNA Viruses / drug effects
  • DNA Viruses / physiology
  • Drug Evaluation, Preclinical
  • Herpesvirus 3, Human / drug effects
  • Herpesvirus 3, Human / physiology*
  • Humans
  • RNA Viruses / drug effects
  • RNA Viruses / physiology
  • Structure-Activity Relationship
  • Uracil / chemistry*
  • Virus Replication / drug effects

Substances

  • Acetamides
  • Antiviral Agents
  • Uracil
  • acetamide